Intercept Pharmaceuticals Inc EV/EBIT
Cos'è EV/EBIT di Intercept Pharmaceuticals Inc?
EV/EBIT di Intercept Pharmaceuticals Inc è N/A
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su NASDAQ rispetto a Intercept Pharmaceuticals Inc
Cosa fa Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Aziende con ev/ebit simili a Intercept Pharmaceuticals Inc
- Country Club Hospitality & Holidays ha EV/EBIT di N/A
- AF2 Capital ha EV/EBIT di N/A
- Relmada Therapeutics Inc ha EV/EBIT di N/A
- Emerge Commerce ha EV/EBIT di N/A
- Bank of Marin Bancorp ha EV/EBIT di N/A
- Vita 34 AG ha EV/EBIT di N/A
- Intercept Pharmaceuticals Inc ha EV/EBIT di N/A
- Raminfo ha EV/EBIT di N/A
- Perceptron ha EV/EBIT di N/A
- Suven Life Sciences ha EV/EBIT di N/A
- Morarjee Textiles ha EV/EBIT di N/A
- Crinetics Pharmaceuticals Inc ha EV/EBIT di N/A
- Ramky Infrastructure ha EV/EBIT di N/A